Page last updated: 2024-10-20

uracil and Myelodysplastic Syndromes

uracil has been researched along with Myelodysplastic Syndromes in 2 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research Excerpts

ExcerptRelevanceReference
"Acute myeloid leukemia was finally diagnosed in October 1998, and chromosomal analysis disclosed inv(3) in addition to -5 and -7."1.31[Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer]. ( Aoki, K; Chiba, S; Hirai, H; Honda, H; Horikoshi, M; Itikawa, M; Kurokawa, M; Machida, U; Masuda, S; Mitani, K; Ogawa, S; Seo, S; Sunaga, S; Yazaki, Y, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horikoshi, M1
Machida, U1
Itikawa, M1
Seo, S1
Masuda, S1
Kurokawa, M1
Ogawa, S1
Sunaga, S1
Honda, H1
Aoki, K1
Chiba, S1
Mitani, K1
Hirai, H1
Yazaki, Y1
Abe, M1
Tanaka, Y1
Shinohara, M1
Kosaka, M1
Matsumoto, T1

Other Studies

2 other studies available for uracil and Myelodysplastic Syndromes

ArticleYear
[Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair

2000
Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.
    British journal of haematology, 2000, Volume: 111, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Drug Administration Schedu

2000